Otros idiomas Oramed Pharmaceuticals Inc.

Acciones

ORMP

US68403P2039

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 07/05/2024			Varia. Cinco días.	Varia. 1 de enero.
2,4 ^USD	-3,61 %		+3,45 %	+3,90 %

19/03	Oramed Pharmaceuticals Inc. Nombra Director a Yehuda Reznick, con efecto a partir del 1 de abril de 2024	CI
06/03	Oramed Pharmaceuticals Inc. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	06/05
Oramed Pharmaceuticals : 13D-Nadav Kidron	26/03
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	19/03
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19/01
Oramed Pharmaceuticals : Other Report or Announcement	02/01
Oramed Pharmaceuticals : Other Report or Announcement	24/12
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	19/12
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.	19/12
Oramed: Q3 Earnings Snapshot	10/11
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Oramed Pharmaceuticals Inc.(TASE:ORMP) dropped from TA-125 Index	03/11
Scilex Consummates Purchase of Securities Owned by Sorrento Therapeutics	21/09/23
Scilex Holding Company announced that it has received $101.875 million in funding from Oramed Pharmaceuticals Inc.	21/09/23
Oramed Pharmaceuticals Inc. cancelled the acquisition of 40.17% stake in Scilex Holding Company from Sorrento Therapeutics, Inc. (OTCPK:SRNE.Q).	21/09/23
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Oramed Pharmaceuticals : Other Report or Announcement	07/08/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Oramed Pharmaceuticals Inc.

Acciones

ORMP

US68403P2039

Otros idiomas

Filtros